Looking Beyond Symptoms in Psychiatric Drug Development
October 15, 2026
Advances in translational science are helping researchers better understand psychiatric disease biology, says Tanya Wallace
8 min read
False
Advertisement
2026
CRISPR Cuts Cholesterol for a Year
October 14, 2026
A single CRISPR infusion sustained reductions in LDL cholesterol and triglycerides for 12 months.
2 min read
Musings From the Power List: Jason Bock
October 14, 2026
Jason Bock shares his outlook on RNA-targeting therapies, personalized medicine, and the future of drug development
12 min read
Bringing CAR T Closer to Home
October 13, 2026
CAR T Vision aims to widen access to cell therapy by expanding community-based delivery, easing operational barriers, and building sustainable funding models
7 min read
CRISPR-Based Delivery System Generates CAR T Cells In Vivo
October 13, 2026
A two-vector delivery system generates tumor-targeting CAR T cells directly inside the body, achieving complete responses in mouse cancer models
3 min read
Caribou Halts Allogeneic CAR T Programs as Funding Pressures Mount
October 12, 2026
“Caribou’s story has taken a heartbreaking turn,” says CEO Rachel Haurwitz, with the CRISPR-focused biotech set to discontinue vispa-cel and CB-011, and reduce its workforce
2 min read
This Month’s Manufacturing Moves
October 12, 2026
Bayer plans a $2.2 billion Ohio campus, Genentech breaks ground in Oregon, and new investments support vaccine production, downstream processing, and manufacturing in orbit
5 min read
Find the Achilles’ Heel: Sitting Down With Amy Jensen-Smith
October 12, 2026
SOTIO Biotech’s CSO explains why drug developers should test their weakest assumptions early, how she builds innovative teams, and where ADCs could go next
8 min read
The Staying Power of Small Molecules
October 8, 2026
We asked the 2026 Power List whether newer modalities have eclipsed small molecules – and where the traditional mainstay still wins
4 min read
Prula-cel Shows Early Promise in Lupus
October 8, 2026
Adicet Bio reports 12-month remission and renal response data for its allogeneic gamma delta CAR T therapy
2 min read
